US Medicare Cost For Part D Redesign Could Far Exceed Earlier Projections, CBO Says

CBO's Score Is An Attention Getter But $10bn Range In Forecast Underscores Uncertainty • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet